Nov 7, 2022 Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients Learn moreEn savoir plus
Nov 1, 2022 November is Crohn’s & Colitis Awareness Month, and We Need Your Help Learn moreEn savoir plus
Oct 20, 2022 Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease Learn moreEn savoir plus
Oct 13, 2022 Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada Learn moreEn savoir plus